Optimizing Ocular Therapy: A Synergistic Approach with Thermosensitive Poloxamer 407 and Chitosan in In Situ Gel Formulation

Thermosensitive in situ gels in ocular drug delivery present a breakthrough in optimizing therapeutic outcomes. Responsive to physiological temperature, these gels undergo a transition from liquid to gel upon contact with the ocular surface. This unique property enhances drug bioavailability and extends retention time, overcoming challenges posed by rapid tear turnover. The gel viscosity promotes sustained drug release, minimizing the need for frequent administrations. In this study, a thermosensitive polymer base of poloxamer 407 was combined with chitosan to produce an in situ levofloxacin gel. Characterisation was carried out to see the effect of both polymers on the physicochemical properties of the resulting gel such as appearance, pH, gelation time and temperature, viscosity, and drug release. Attenuated Total Reflector (ATR) spectroscopy was employed to investigate the molecular interactions. Subsequently, the antibacterial activity was comparatively evaluated with a market product. This study aimed to develop Levofloxacin (LFX) in situ gel using poloxamer 407 (PLX407) and chitosan (CHT). Both polymers significantly influenced gelation characteristics, aligning with physiological eye mucosa temperature (34°C). PLX407's thermosensitivity played a vital role in gelation, decreasing solubility with temperature rise. Synergistic involvement of PLX407 and CHT resulted in lower gelation temperatures and times with higher PLX407 concentrations. At low CHT concentrations (<0.4%), increased concentration decreased gelation time. CHT's ability to accelerate dehydration and form crosslinks enhanced gel strength. The drug release profile followed a first-order model, suggesting controlled release, but the Korsmeyer-Peppas model indicated a super case II mechanism. In practice, shear forces and dilution lead to dissolution and erosion, but the dialysis membrane may restrict observation. This highlights the importance of practical relevance in experimental design.

Authors

Institutions

Publication Details

Journal
Research Journal of Pharmacy and Technology
Published
2024-11-18
DOI
https://doi.org/10.52711/0974-360x.2024.00817
Citations
2
Primary Topic
Advanced Drug Delivery Systems
Type
article
Field-Weighted Citation Impact
0.42
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Optimizing Ocular Therapy: A Synergistic Approach with Thermosensitive Poloxamer 407 and Chitosan in In Situ Gel Formulation

Ronny Martien, Adhyatmika Adhyatmika, Muhammad Seftian, Umaimatun Nakhil
2 citations
Research Journal of Pharmacy and Technology
Advanced Drug Delivery Systems
0.42
article

Optimizing Ocular Therapy: A Synergistic Approach with Thermosensitive Poloxamer 407 and Chitosan in In Situ Gel Formulation

Ronny Martien, Adhyatmika Adhyatmika, Muhammad Seftian, Umaimatun Nakhil
article en
2 citations

Abstract

Thermosensitive in situ gels in ocular drug delivery present a breakthrough in optimizing therapeutic outcomes. Responsive to physiological temperature, these gels undergo a transition from liquid to gel upon contact with the ocular surface. This unique property enhances drug bioavailability and extends retention time, overcoming challenges posed by rapid tear turnover. The gel viscosity promotes sustained drug release, minimizing the need for frequent administrations. In this study, a thermosensitive polymer base of poloxamer 407 was combined with chitosan to produce an in situ levofloxacin gel. Characterisation was carried out to see the effect of both polymers on the physicochemical properties of the resulting gel such as appearance, pH, gelation time and temperature, viscosity, and drug release. Attenuated Total Reflector (ATR) spectroscopy was employed to investigate the molecular interactions. Subsequently, the antibacterial activity was comparatively evaluated with a market product. This study aimed to develop Levofloxacin (LFX) in situ gel using poloxamer 407 (PLX407) and chitosan (CHT). Both polymers significantly influenced gelation characteristics, aligning with physiological eye mucosa temperature (34°C). PLX407's thermosensitivity played a vital role in gelation, decreasing solubility with temperature rise. Synergistic involvement of PLX407 and CHT resulted in lower gelation temperatures and times with higher PLX407 concentrations. At low CHT concentrations (<0.4%), increased concentration decreased gelation time. CHT's ability to accelerate dehydration and form crosslinks enhanced gel strength. The drug release profile followed a first-order model, suggesting controlled release, but the Korsmeyer-Peppas model indicated a super case II mechanism. In practice, shear forces and dilution lead to dissolution and erosion, but the dialysis membrane may restrict observation. This highlights the importance of practical relevance in experimental design.

Research Journal of Pharmacy and Technology
Universitas Gadjah Mada (ID)
Openalex Percentile: Top 40%
Advanced Drug Delivery Systems
0.42
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.